@msolly.bsky.social @msolly.bsky.social 
Emily Hayes @emilyhayes.bsky.social Writer | Editor | Medical Journalist | Biopharma Analyst | Singer
@5knew.bsky.social @5knew.bsky.social 
Jeanne Whalen @jeannewhalen.bsky.social Economics reporter at The Wall Street Journal, based in Chicago. Past stints in Moscow, London, NYC and DC.
Madeleine Armstrong @bymadeleinea.bsky.social Reporter at ApexOnco, Bluesky lurker (for now)
Madeleine Armstrong @madeleinewrite.bsky.social Writer, runner, trying to keep up with another social media platform
Paul Rennert @pdrworld.bsky.social Biotech exec, pro drug developer. Amateur everything else: COOKING, ferments, preserving, charcuterie, fishing, gardening, weightlifting, BIRDER, photography, physics, literature, writer, history, DAD
David Miller @biotechmiller.bsky.social 20+ years in the biotech business. Analyst, portfolio manager, VC, & now doing corporate communications and strategy. Avid sailor who races. All views are my own.
One life, right? Don't blow it.
Raffaele Colombo @raffcolo.bsky.social ADCs, targeted therapies, chemistry, biotech, pharma.
Associate Director @ Zymeworks
Sally Church @maverickny.bsky.social Scientist, cancer geek, journalist, Londoner, always curious, adventurer, explorer, immigrant, lover of curry, fine wine & football
Bruce Levine, Ph.D. 🇺🇦 @bllphd.bsky.social 🧬🧪Professor @Pennmedicine #CellTherapy #Genetherapy #Inventor #Kymriah #CARTCell @TmunityTx & @CapstanTx CoFounder, Past President @ISCTGlobal @PNASNexus AE
https://orcid.org/0000-0001-6971-8465
Mark Paris @geneman10.bsky.social | Genetics PhD | Likes, posts, reposts are my own | Global Head, Oncology Search and Evaluation - Daiichi Sankyo BD
Lisa Jarvis @lisamjarvis.bsky.social Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
Jing Liang @applehelix.bsky.social Entrepreneur. Drug hunter. Novice biotech scripophile. Anti-ideologues. Proudly blocked by
Vinay Prasad. http://linkedin.com/in/jliang1/
Matthew Herper @matthewherper.bsky.social I write about medicine at STAT. This is biology's century. Every data point has a face.
Investor Clouseau, Ph.D. @investrclouseau.bsky.social Not a CFA, biotech investor, still recovering from a decade in neuroscience, so now focusing on drugs that work
Derek Lowe @dereklowe.bsky.social Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18
All opinions are mine; I don’t speak for my employer in any way.
Sam Blackman 🥖 @drsam.bsky.social Pediatric oncologist. Cancer drug developer. Dad joke aficionado. Moth GrandSLAM winner. Climber of mountains. Raconteur. Baker. Orcasonian. Entrepreneur-in-Residence @ GV.
I'm also at https://substack.com/@drsamblackman
Frank S. David @franksdavid.bsky.social Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
Elaine Chen @elaineywchen.bsky.social Reporter @statnews.com covering drugs and the biopharma industry | signal: elaineywchen.70
Simon Bayly @simonbayly.bsky.social Reformed chemist 👨🔬 IP licensing and spinouts at the Francis Crick Institute. Also post about cycling 🚲 Opinion my own etc.
Antonio Regalado @antonioregalado.bsky.social Journalist covering biotechnology for MIT Technology Review. Scoops about new methods in genetics and cell biology. The "playing God" beat. Gene editing, gene therapy, ancient DNA, synthetic embryos, cloning, etc. 
Pearl Freier @pearlf.bsky.social From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items. 
Adam Feuerstein✡️ @adamfeuerstein.bsky.social Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.